(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-cyclohexylbutanoic acid, 97%, 100g

Methyl 4-Chloropyridine-2-carboxylate, 97.0%, 5g

N,N-Bis[(1S)-1-phenylethyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, ?97.0%, 5g

(2R,3R)-2-(2,4-DIFLUOROPHENYL)-3-(4-METHYLENEPIPERIDIN-1-YL)-1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL, 97.0%, 250mg

Azetidine-1-sulfonamide, 97%, 500mg

2-Methyl-N-phenylbenzamide, 98.0%, 250mg

(S)-4-(1-(tert-butoxycarbonyl)ethyl)benzoic acid, 98%, 50mg

4-Chloro-6-methyl-2-(methylthio)pyrimidine-5-carbonitrile, 95.0%, 5g

Benzyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate, 98%, 10g

(4-Chloro-3-hydroxy-phenyl)-carbamic acid tert-butyl ester, 95.0%, 500mg

2-Phenoxyethyl Methacrylate (stabilized with HQ + MEHQ)>85.0%(GC)100g

2-Chloro-1-(2,4-dichlorophenyl)ethan-1-ol, 97%, 100mg

1-(tert-Butoxycarbonyl)-4-piperidone>98.0%(GC)5g